Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SIMVASTATIN vs SIPONIMOD: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SIMVASTATIN vs SIPONIMOD: Safety Overview

Metric SIMVASTATIN SIPONIMOD
Total FAERS Reports 27,079 8,581
Deaths Reported 2,792 196
Death Rate 10.3% 2.3%
Hospitalizations 8,824 1,396
Average Patient Age 66.6 yrs 53.8 yrs
% Female Patients 47.5% 74.4%
FDA Approval Date Apr 14, 2009 Apr 22, 2025
Manufacturer Aphena Pharma Solutions - Tennessee, LLC Novartis Pharmaceuticals Corporation
Route ORAL ORAL
Marketing Status Prescription Prescription